We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Humanigen Announces Positive Trial Data for COVID-19 Antibody, Drawing Criticism
Humanigen Announces Positive Trial Data for COVID-19 Antibody, Drawing Criticism
Humanigen on Friday revealed positive interim data in a late-stage clinical trial of its monoclonal antibody lenzilumab for the treatment of COVID-19 patients, but a trial design expert contended that the disclosure was inappropriate and could put the trial’s integrity at risk.